 Peter Kennealey
Concepts (152)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Kidney Transplantation | 11 | 2026 | 712 | 1.670 |
Why?
| | Kidney Failure, Chronic | 7 | 2025 | 599 | 1.160 |
Why?
| | Thrombelastography | 4 | 2023 | 192 | 0.830 |
Why?
| | Tissue Plasminogen Activator | 2 | 2023 | 248 | 0.720 |
Why?
| | Pancreas Transplantation | 2 | 2018 | 71 | 0.670 |
Why?
| | Organ Transplantation | 5 | 2023 | 253 | 0.650 |
Why?
| | Blood Coagulation | 2 | 2023 | 274 | 0.600 |
Why?
| | Gastrectomy | 3 | 2026 | 166 | 0.590 |
Why?
| | Carotid Arteries | 1 | 2019 | 208 | 0.550 |
Why?
| | Renal Dialysis | 3 | 2023 | 466 | 0.550 |
Why?
| | Liver Transplantation | 5 | 2024 | 827 | 0.540 |
Why?
| | HLA Antigens | 1 | 2019 | 240 | 0.540 |
Why?
| | Tissue and Organ Procurement | 5 | 2026 | 343 | 0.530 |
Why?
| | Obesity, Morbid | 3 | 2026 | 293 | 0.500 |
Why?
| | Simulation Training | 1 | 2018 | 136 | 0.460 |
Why?
| | General Surgery | 1 | 2018 | 206 | 0.440 |
Why?
| | Vascular Surgical Procedures | 1 | 2018 | 343 | 0.420 |
Why?
| | Tissue Donors | 4 | 2026 | 420 | 0.400 |
Why?
| | Robotic Surgical Procedures | 2 | 2026 | 185 | 0.390 |
Why?
| | Education, Medical, Graduate | 1 | 2018 | 562 | 0.370 |
Why?
| | Peritoneal Dialysis | 2 | 2024 | 100 | 0.360 |
Why?
| | Graft Survival | 6 | 2026 | 519 | 0.330 |
Why?
| | Brain Death | 2 | 2026 | 60 | 0.310 |
Why?
| | Clinical Competence | 1 | 2018 | 1247 | 0.300 |
Why?
| | Resuscitation | 2 | 2024 | 312 | 0.300 |
Why?
| | Hernia, Ventral | 1 | 2009 | 24 | 0.290 |
Why?
| | Catheters, Indwelling | 2 | 2024 | 96 | 0.240 |
Why?
| | Health Services Accessibility | 2 | 2025 | 1101 | 0.240 |
Why?
| | Living Donors | 3 | 2021 | 282 | 0.240 |
Why?
| | Receptors, Gastrointestinal Hormone | 1 | 2025 | 7 | 0.220 |
Why?
| | Middle Aged | 15 | 2026 | 36309 | 0.210 |
Why?
| | Laparoscopy | 3 | 2024 | 481 | 0.210 |
Why?
| | Female | 21 | 2026 | 79045 | 0.180 |
Why?
| | Male | 19 | 2026 | 73012 | 0.180 |
Why?
| | Informed Consent | 1 | 2024 | 199 | 0.180 |
Why?
| | Humans | 32 | 2026 | 145785 | 0.180 |
Why?
| | Directed Tissue Donation | 1 | 2021 | 5 | 0.170 |
Why?
| | Cardiovascular System | 1 | 2023 | 139 | 0.170 |
Why?
| | Markov Chains | 3 | 2026 | 132 | 0.160 |
Why?
| | Reperfusion | 1 | 2020 | 54 | 0.160 |
Why?
| | Adult | 12 | 2026 | 40882 | 0.150 |
Why?
| | Kidney Function Tests | 1 | 2020 | 156 | 0.150 |
Why?
| | Hemostatic Techniques | 1 | 2020 | 52 | 0.150 |
Why?
| | Feasibility Studies | 1 | 2024 | 1115 | 0.150 |
Why?
| | Blood Component Transfusion | 1 | 2020 | 103 | 0.150 |
Why?
| | Postoperative Period | 1 | 2020 | 351 | 0.150 |
Why?
| | Renal Insufficiency, Chronic | 1 | 2026 | 668 | 0.150 |
Why?
| | Treatment Outcome | 8 | 2026 | 11794 | 0.140 |
Why?
| | Retrospective Studies | 9 | 2026 | 17330 | 0.140 |
Why?
| | Blood Coagulation Disorders | 1 | 2020 | 198 | 0.140 |
Why?
| | Predictive Value of Tests | 2 | 2020 | 2123 | 0.130 |
Why?
| | Prospective Studies | 4 | 2020 | 8078 | 0.130 |
Why?
| | Registries | 2 | 2024 | 2410 | 0.130 |
Why?
| | Anastomosis, Surgical | 1 | 2018 | 164 | 0.130 |
Why?
| | Cattle | 1 | 2019 | 946 | 0.130 |
Why?
| | Transplantation, Homologous | 1 | 2018 | 419 | 0.130 |
Why?
| | Decision Support Techniques | 3 | 2026 | 480 | 0.120 |
Why?
| | Family | 1 | 2021 | 685 | 0.120 |
Why?
| | Death | 2 | 2023 | 132 | 0.120 |
Why?
| | Magnetic Resonance Spectroscopy | 2 | 2011 | 627 | 0.110 |
Why?
| | Weight Loss | 3 | 2026 | 859 | 0.110 |
Why?
| | Aged | 7 | 2026 | 26217 | 0.110 |
Why?
| | Diabetes Complications | 1 | 2016 | 225 | 0.110 |
Why?
| | Diabetic Nephropathies | 1 | 2018 | 322 | 0.110 |
Why?
| | Obesity | 2 | 2025 | 3118 | 0.100 |
Why?
| | Catheterization | 2 | 2024 | 184 | 0.100 |
Why?
| | Postoperative Complications | 3 | 2024 | 2977 | 0.090 |
Why?
| | Body Mass Index | 3 | 2026 | 2447 | 0.090 |
Why?
| | Bariatric Surgery | 2 | 2026 | 253 | 0.090 |
Why?
| | Polytetrafluoroethylene | 1 | 2011 | 23 | 0.080 |
Why?
| | Vascular Patency | 1 | 2011 | 121 | 0.080 |
Why?
| | Protons | 1 | 2011 | 96 | 0.080 |
Why?
| | Fibrinolysis | 2 | 2023 | 164 | 0.080 |
Why?
| | Blood Vessel Prosthesis | 1 | 2011 | 140 | 0.080 |
Why?
| | Flavonoids | 2 | 2011 | 85 | 0.080 |
Why?
| | Waiting Lists | 2 | 2021 | 266 | 0.070 |
Why?
| | Prognosis | 1 | 2018 | 4330 | 0.070 |
Why?
| | Piperidines | 2 | 2011 | 222 | 0.070 |
Why?
| | Surgical Mesh | 1 | 2009 | 50 | 0.070 |
Why?
| | United States | 5 | 2024 | 16126 | 0.070 |
Why?
| | Nephrectomy | 1 | 2009 | 163 | 0.070 |
Why?
| | Xenograft Model Antitumor Assays | 1 | 2011 | 936 | 0.070 |
Why?
| | Internship and Residency | 1 | 2018 | 1269 | 0.060 |
Why?
| | Biocompatible Materials | 1 | 2011 | 429 | 0.060 |
Why?
| | Aged, 80 and over | 1 | 2019 | 8347 | 0.060 |
Why?
| | Apoptosis | 3 | 2011 | 2445 | 0.060 |
Why?
| | Delayed Graft Function | 1 | 2026 | 46 | 0.060 |
Why?
| | Gastrointestinal Stromal Tumors | 1 | 2006 | 41 | 0.060 |
Why?
| | Proto-Oncogene Proteins c-kit | 1 | 2006 | 72 | 0.060 |
Why?
| | Creatinine | 2 | 2023 | 515 | 0.060 |
Why?
| | Operative Time | 1 | 2026 | 181 | 0.060 |
Why?
| | Surveys and Questionnaires | 1 | 2018 | 6085 | 0.050 |
Why?
| | Abdomen | 1 | 2024 | 142 | 0.050 |
Why?
| | Colorectal Neoplasms | 1 | 2011 | 868 | 0.050 |
Why?
| | Young Adult | 1 | 2019 | 14254 | 0.050 |
Why?
| | Canada | 1 | 2024 | 432 | 0.050 |
Why?
| | Platelet Count | 1 | 2022 | 94 | 0.050 |
Why?
| | Abdominal Pain | 1 | 2024 | 149 | 0.050 |
Why?
| | Organ Preservation | 1 | 2023 | 125 | 0.040 |
Why?
| | Platelet Transfusion | 1 | 2022 | 77 | 0.040 |
Why?
| | Patients | 1 | 2023 | 183 | 0.040 |
Why?
| | Altruism | 1 | 2021 | 27 | 0.040 |
Why?
| | Perfusion | 1 | 2023 | 251 | 0.040 |
Why?
| | Kidney | 1 | 2009 | 1497 | 0.040 |
Why?
| | Diabetes Mellitus, Type 1 | 1 | 2018 | 3937 | 0.040 |
Why?
| | Intraoperative Period | 1 | 2020 | 69 | 0.040 |
Why?
| | Computer Systems | 1 | 2020 | 55 | 0.040 |
Why?
| | Viscosity | 1 | 2020 | 92 | 0.040 |
Why?
| | Liver Function Tests | 1 | 2020 | 105 | 0.040 |
Why?
| | Adolescent | 1 | 2019 | 22577 | 0.040 |
Why?
| | Length of Stay | 1 | 2026 | 1350 | 0.040 |
Why?
| | Blood Platelets | 1 | 2022 | 379 | 0.040 |
Why?
| | Antineoplastic Agents | 2 | 2011 | 2219 | 0.040 |
Why?
| | Animals | 2 | 2019 | 38106 | 0.040 |
Why?
| | Patient Selection | 2 | 2016 | 739 | 0.040 |
Why?
| | Survival Rate | 2 | 2016 | 2094 | 0.030 |
Why?
| | Aging | 1 | 2008 | 1973 | 0.030 |
Why?
| | Critical Care | 1 | 2023 | 702 | 0.030 |
Why?
| | Teratocarcinoma | 1 | 1995 | 2 | 0.030 |
Why?
| | Time Factors | 2 | 2020 | 7134 | 0.030 |
Why?
| | Pandemics | 1 | 2021 | 1711 | 0.020 |
Why?
| | Cell Cycle | 2 | 2011 | 598 | 0.020 |
Why?
| | Choline Kinase | 1 | 2011 | 3 | 0.020 |
Why?
| | Choline-Phosphate Cytidylyltransferase | 1 | 2011 | 3 | 0.020 |
Why?
| | Phosphorus Isotopes | 1 | 2011 | 8 | 0.020 |
Why?
| | HCT116 Cells | 1 | 2011 | 76 | 0.020 |
Why?
| | Cohort Studies | 1 | 2021 | 6033 | 0.020 |
Why?
| | Camptothecin | 1 | 2011 | 138 | 0.020 |
Why?
| | Neoplasms | 1 | 2004 | 2913 | 0.020 |
Why?
| | Angiography | 1 | 2009 | 208 | 0.020 |
Why?
| | Saccharomyces cerevisiae | 1 | 2011 | 574 | 0.020 |
Why?
| | Imatinib Mesylate | 1 | 2006 | 77 | 0.010 |
Why?
| | Brain Injuries | 1 | 2010 | 507 | 0.010 |
Why?
| | Benzamides | 1 | 2006 | 226 | 0.010 |
Why?
| | Graft Rejection | 1 | 2008 | 521 | 0.010 |
Why?
| | Body Water | 1 | 2004 | 23 | 0.010 |
Why?
| | Hydrogen | 1 | 2004 | 73 | 0.010 |
Why?
| | Down-Regulation | 1 | 2006 | 618 | 0.010 |
Why?
| | Piperazines | 1 | 2006 | 375 | 0.010 |
Why?
| | Tumor Cells, Cultured | 1 | 2004 | 887 | 0.010 |
Why?
| | RNA Polymerase II | 1 | 2006 | 350 | 0.010 |
Why?
| | Pyrimidines | 1 | 2006 | 530 | 0.010 |
Why?
| | Phosphorylation | 1 | 2006 | 1708 | 0.010 |
Why?
| | Promoter Regions, Genetic | 1 | 2006 | 1247 | 0.010 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 2011 | 1969 | 0.010 |
Why?
| | Transcription, Genetic | 1 | 2006 | 1454 | 0.010 |
Why?
| | Follow-Up Studies | 1 | 2008 | 5428 | 0.010 |
Why?
| | Cell Line, Tumor | 1 | 2006 | 3551 | 0.010 |
Why?
| | Genes, p53 | 1 | 1995 | 67 | 0.010 |
Why?
| | Dose-Response Relationship, Radiation | 1 | 1995 | 141 | 0.010 |
Why?
| | Mice | 1 | 2011 | 18358 | 0.010 |
Why?
| | Cell Survival | 1 | 1995 | 1105 | 0.010 |
Why?
|
|
Kennealey's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|